AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,178,000 | +1588.9% | 151,117 | +907.4% | 2.65% | +904.5% |
| Q4 2018 | $425,000 | -92.8% | 15,000 | -88.0% | 0.26% | -90.6% |
| Q3 2018 | $5,908,000 | +492.0% | 125,179 | +747.0% | 2.81% | +633.2% |
| Q2 2018 | $998,000 | +24.4% | 14,779 | 0.0% | 0.38% | +22.4% |
| Q1 2018 | $802,000 | -9.2% | 14,779 | 0.0% | 0.31% | +0.6% |
| Q4 2017 | $883,000 | +23.0% | 14,779 | 0.0% | 0.31% | +11.5% |
| Q3 2017 | $718,000 | -85.4% | 14,779 | -84.2% | 0.28% | -85.1% |
| Q2 2017 | $4,926,000 | +624.4% | 93,822 | +525.5% | 1.87% | +620.0% |
| Q1 2017 | $680,000 | -86.9% | 15,000 | -89.1% | 0.26% | -88.9% |
| Q4 2016 | $5,210,000 | – | 138,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |